UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
Agilon Health
AGL
$1.6B
| $2.5M | ﹤0.01% |
52,644
+27,018
| +105% | +$1.63M |
|
4502
Perimeter Solutions
PRM
$5.77B
| $2.5M | ﹤0.01% |
195,622
+105,056
| +116% | +$1.37M |
|
4503
Cannae Holdings
CNNE
$649M
| $2.5M | ﹤0.01% |
125,811
+70,767
| +129% | +$1.42M |
|
4504
Invesco Oil & Gas Services ETF
PXJ
$62.2M
| $2.5M | ﹤0.01% |
89,648
-5,359
| -6% | -$155K |
|
|
GRW
4505
TCW ETF Trust TCW Durable Growth ETF
GRW
$66.8M
| $2.5M | ﹤0.01% |
75,951
+19,859
| +35% | +$742K |
|
4506
Senseonics Holdings Inc
SENS
$366M
| $2.49M | ﹤0.01% |
238,459
+235,694
| +8,524% | +$1.68M |
|
4507
PUT
Cadence Design Systems
CDNS
$93.4B
| $2.49M | ﹤0.01% |
+8,300
| New | +$2.41M |
|
4508
Natural Gas Services Group
NGS
$477M
| $2.49M | ﹤0.01% |
93,032
+74,487
| +402% | +$1.75M |
|
4509
First Commonwealth Financial
FCF
$2.17B
| $2.49M | ﹤0.01% |
147,237
+50,609
| +52% | +$894K |
|
|
FPF
4510
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
| $2.49M | ﹤0.01% |
138,326
-9,131
| -6% | -$171K |
|
|
SNBR
4511
DELISTED
Sleep Number
SNBR
| $2.49M | ﹤0.01% |
163,362
+132,948
| +437% | +$2.06M |
|
4512
Cohu
COHU
$2.5B
| $2.49M | ﹤0.01% |
93,157
+30,410
| +48% | +$796K |
|
|
MMD
4513
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$282M
| $2.49M | ﹤0.01% |
166,577
+51,287
| +44% | +$829K |
|
4514
Invesco Quality Municipal Securities
IQI
$534M
| $2.48M | ﹤0.01% |
251,925
-4,557
| -2% | -$46K |
|
|
SEPN
4515
Septerna Inc
SEPN
$1.75B
| $2.48M | ﹤0.01% |
+108,453
| New | +$2.56M |
|
|
LENZ
4516
LENZ Therapeutics
LENZ
$168M
| $2.48M | ﹤0.01% |
85,928
+79,783
| +1,298% | +$2.43M |
|
4517
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$715M
| $2.48M | ﹤0.01% |
105,777
-9,582
| -8% | -$225K |
|
4518
dLocal
DLO
$4.24B
| $2.48M | ﹤0.01% |
219,918
+101,940
| +86% | +$1.03M |
|
|
DCH
4519
Dauch Corp
DCH
$1.51B
| $2.46M | ﹤0.01% |
422,595
+287,223
| +212% | +$1.8M |
|
4520
Wipro
WIT
$20B
| $2.46M | ﹤0.01% |
695,509
+533,573
| +329% | +$1.83M |
|
4521
Immersion
IMMR
$252M
| $2.46M | ﹤0.01% |
281,673
+261,770
| +1,315% | +$2.29M |
|
4522
Edgewise Therapeutics
EWTX
$4.73B
| $2.46M | ﹤0.01% |
92,066
+16,761
| +22% | +$534K |
|
|
MTAL
4523
DELISTED
Metals Acquisition
MTAL
| $2.46M | ﹤0.01% |
231,326
+205,620
| +800% | +$2.54M |
|
4524
Fidus Investment
FDUS
$772M
| $2.45M | ﹤0.01% |
116,610
+47,973
| +70% | +$972K |
|
|
SLN
4525
Silence Therapeutics
SLN
$564M
| $2.45M | ﹤0.01% |
356,071
+285,410
| +404% | +$3.68M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.